<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03138434</url>
  </required_header>
  <id_info>
    <org_study_id>NL56823.018.16</org_study_id>
    <nct_id>NCT03138434</nct_id>
  </id_info>
  <brief_title>Advanced MRI in AAA</brief_title>
  <official_title>Advanced MRI in AAA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ron Balm</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine whether advanced MRI sequences can provide robust and clinically
      relevant information about abdominal aortic aneurysms (AAAs). The MRI sequences will study
      outcomes related to blood flow inside AAA, microvasculature of the AAA vessel wall and
      intraluminal thrombus inside AAA.

      Robustness of these MRI sequences will be determined with testing of feasibility and
      reproducibility. Clinical relevance will be assessed by studying the association between the
      primary outcomes and disease severity. Disease severity will be expressed by AAA diameter.

      It is our hypothesis that these parameters are significantly related to disease severity and
      may therefore be future markers of disease progression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective study evaluates the feasibility, reproducibility and clinical relevance of
      MRI sequences in adults with an abdominal aortic aneurysm (AAA).

      The MRI sequences and their primary outcomes are:

        -  Four-dimensional (4D) flow MRI and wall shear stress (WSS)

        -  Dynamic Contrast-Enhanced (DCE) MRI and kinetic transport constant (Ktrans)

        -  T1 and T2 mapping (T1 and T2 relaxation times)

      Feasibility is tested by the production of high-quality images that enable calculation of the
      primary outcomes. Reproducibility is tested by calculating interscan, intra- and
      interobserver variability. Clinical relevance is tested by assessing the association between
      primary outcomes and disease severity which is expressed by AAA diameter
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 12, 2017</start_date>
  <completion_date type="Anticipated">September 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Wall shear stress (WSS)</measure>
    <time_frame>Time of MRI scan</time_frame>
    <description>Primary outcome of 4D flow MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Kinetic transport constant (Ktrans)</measure>
    <time_frame>Time of MRI scan</time_frame>
    <description>Primary outcome of DCE-MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>T1 relaxation time</measure>
    <time_frame>Time of MRI scan</time_frame>
    <description>Primary outcome of T1 mapping</description>
  </primary_outcome>
  <primary_outcome>
    <measure>T2 relaxation time</measure>
    <time_frame>Time of MRI scan</time_frame>
    <description>Primary outcome of T2 mapping</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peak flow velocity inside the aneurysm</measure>
    <time_frame>Time of MRI scan</time_frame>
    <description>Secondary outcome of 4D flow MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Location of peak wall shear stress</measure>
    <time_frame>Time of MRI scan</time_frame>
    <description>Secondary outcome of 4D flow MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flow velocity at aneurysm entrance</measure>
    <time_frame>Time of MRI scan</time_frame>
    <description>Secondary outcome of 4D flow MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flow patterns</measure>
    <time_frame>Time of MRI scan</time_frame>
    <description>Secondary outcome of 4D flow MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oscillatory shear index</measure>
    <time_frame>Time of MRI scan</time_frame>
    <description>Secondary outcome of 4D flow MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reverse reflux rate constant (kep)</measure>
    <time_frame>Time of MRI scan</time_frame>
    <description>Secondary outcome of DCE-MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area under the curve of contrast uptake</measure>
    <time_frame>Time of MRI scan</time_frame>
    <description>Secondary outcome of DCE-MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak enhancement ratio</measure>
    <time_frame>Time of MRI scan</time_frame>
    <description>Secondary outcome of DCE-MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wash-in slope</measure>
    <time_frame>Time of MRI scan</time_frame>
    <description>Secondary outcome of DCE-MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to peak (TTP)</measure>
    <time_frame>Time of MRI scan</time_frame>
    <description>Secondary outcome of DCE-MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean transit time (MTT)</measure>
    <time_frame>Time of MRI scan</time_frame>
    <description>Secondary outcome of DCE-MRI</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Abdominal Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>Optimization phase</arm_group_label>
    <description>The first five patients will be included for the optimization of the MRI sequences. This is to ensure that a standard protocol will work for different sizes of AAA. These patients will only be scanned once.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study phase</arm_group_label>
    <description>This phase will commence after the optimization phase. This phase is where we want to assess the feasibility, reproducibility and association with disease severity between MRI parameters and AAA.
These twenty patients will be scanned twice, with an interval of 1 week ± 5 days.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with an abdominal aortic aneurysms who are patients at the department of
        vascular surgery of the Academic Medical Center.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (≥ 18 years of age)

          -  Abdominal aortic aneurysm with a maximal aneurysm diameter of at least 30 mm

        Exclusion Criteria:

          -  Contra-indications for MRI

          -  Severely reduced renal function (eGFR &lt; 30)

          -  Previous allergic reaction to intravenous contrast agents

          -  Suprarenal AAA

          -  Pararenal AAA

          -  Previous aneurysm repair

          -  Inflammatory aneurysm

          -  Mycotic or other infectious aneurysm

          -  Vasculitis

          -  Connective tissue disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ron Balm, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Reza Indrakusuma, MD</last_name>
    <phone>+31205663405</phone>
    <email>r.indrakusuma@amc.uva.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hamid Jalalzadeh, MD</last_name>
    <phone>+31205663437</phone>
    <email>h.jalalzadeh@amc.uva.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Vascular Surgery</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reza Indrakusuma, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2017</study_first_submitted>
  <study_first_submitted_qc>May 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2017</study_first_posted>
  <last_update_submitted>May 5, 2017</last_update_submitted>
  <last_update_submitted_qc>May 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>Ron Balm</investigator_full_name>
    <investigator_title>prof. dr.</investigator_title>
  </responsible_party>
  <keyword>Abdominal Aortic Aneurysm</keyword>
  <keyword>4D flow MRI</keyword>
  <keyword>DCE-MRI</keyword>
  <keyword>T1 and T2 mapping</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

